Open AccessTrends in Pediatric Pneumococcal Pleural Empyema Following Pneumococcal Conjugate 13-Valent Vaccination: 10 Years of Active Surveillance in a Mexican Hospital
Author(s) -
Enrique ChacónCruz,
Erika Zoe Lopatynsky-Reyes,
Rosa Maria Rivas-Landeros,
Maria Luisa Volker-Soberanes,
Jorge Arturo Alvelais-Palacios
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw172.637
Subject(s) - medicine , empyema , vaccination , pediatrics , pneumococcal conjugate vaccine , pneumococcal vaccination , pneumococcal disease , streptococcus pneumoniae , intensive care medicine , virology , antibiotics , surgery , microbiology and biotechnology , biology
• We have previously published the first Mexican study showing a decrease in pneumococcal invasive disease following implementation of the 13-valent pneumococcal conjugate vaccine (PCV13), however, the impact of this vaccine on Pneumococcal Pleural Empyema (PPE), serotypes distribution, and appearance by other non-pneumococcal bacteriae has not been yet published. The Tijuana, Mexico and San Diego, California border is considered the most transited border in the world.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom